Form 4: Charles River Laboratories Executive Disposes Shares for Tax Obligations

Michael G. Knell, CSVP & Chief Accounting Officer of Charles River Laboratories, reported the disposition of 112 common shares over three days in May 2025 to satisfy tax withholding obligations.

Summary

• Michael G. Knell, the CSVP & Chief Accounting Officer of Charles River Laboratories International, Inc. (CRL), filed a Form 4 reporting changes in his beneficial ownership.
• Between May 26, 2025, and May 28, 2025, Mr. Knell disposed of a total of 112 shares of common stock.
• The dispositions were made to satisfy tax withholding obligations, indicated by transaction code 'F'.
• On May 26, 2025, 50 shares were disposed at a price of $136.73 per share.
• On May 27, 2025, 37 shares were disposed at a price of $136.73 per share.
• On May 28, 2025, 25 shares were disposed at a price of $138.65 per share.
• Following these transactions, Mr. Knell beneficially owns 8,743 shares of Charles River Laboratories common stock directly.

Sentiment

Score: 5

Explanation: The filing reports routine share dispositions for tax withholding purposes by an executive, which is a common practice and does not indicate a change in company fundamentals or executive sentiment. Therefore, the sentiment is neutral.

Positives

• The transactions are routine dispositions for tax withholding purposes, which is a common practice for executives receiving equity compensation and does not indicate a lack of confidence in the company.
• The executive retains a substantial holding of 8,743 shares, indicating continued alignment with shareholder interests.

Negatives

• No inherent negatives are identified from this routine tax-related disposition.

Risks

• The document itself does not introduce new risks; it reports a standard insider transaction.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine insider transaction report specific to Charles River Laboratories and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The impact on shareholders is minimal. These are routine tax-related dispositions, not open market sales indicating a lack of confidence. The executive retains a significant stake, maintaining alignment with shareholder interests.

Key Dates

Recommendation

Keywords

Charles River Laboratories, CRL, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Executive Compensation, Michael Knell